Effectiveness and Tolerability of Rabeprazole 20mg as Once-Daily Monotherapy in Treatment of Erosive or Ulcerative Gastro-Oesophageal Reflux Disease

Author： Alves de Freitas J.

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.5, 2002-05, pp. : 279-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of rabeprazole in the treatment of gastro-oesophageal reflux disease

By Thjodleifsson Bjarni

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 137-149

Informa Healthcare

Access to resources Recommend Favorite

Role of pantoprazole in the treatment of gastro-oesophageal reflux disease

By Lehmann Frank Serge Beglinger Christoph

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 93-104

Informa Healthcare

Access to resources Recommend Favorite

Pilot Study of On-Demand Therapy with Pantoprazole 20mg for Long-Term Treatment in Patients with Mild Gastro-Oesophageal Reflux Disease

By Scholten Theo

Clinical Drug Investigation, Vol. 25, Iss. 10, 2005-01 ,pp. : 633-642

Adis International

Access to resources Recommend Favorite

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms

By Röhss Kerstin Lind Tore Wilder-Smith Clive

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 531-539

Springer Publishing Company

Access to resources Recommend Favorite

Cost Effectiveness of Omeprazole and Ranitidine in Intermittent Treatment of Symptomatic Gastro-Oesophageal Reflux Disease

By Weir D.G.

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 483-497

Adis International

Access to resources Recommend Favorite